Product Description
As the number of surgeries performed continues to increase year over year in the U.S., the need for medical sealants will grow accordingly. Over the forecast period, plant-based synthetics will grow in popularity, due to the potential risk of viral disease transmission inherent in plasma-derived products. In addition, price erosion in the synthetic market will encourage the switch to this increasingly affordable market.
Tissue sealants and glues are used in certain surgical procedures and for some types of bleeding to seal the edges of tissue together. Thus, tissue sealants can also be used to seal blood vessels, causing hemostasis. Even though some products are indicated only for tissue sealing, they can also be used off-label as a hemostat.
Segments Covered in This Market
- Fibrin-Based Tissue Sealant Market
- Protein-Based Tissue Sealant Market
- Synthetic Tissue Sealant Market
Report Data Types Included
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares
- Product Portfolios
- Related Press Releases from Top Competitors
Companies Analyzed
Of the many companies in the United States Tissue Sealant market, Baxter was the leader, followed by Ethicon and Integra LifeSciences. In 2018, Baxter acquired Preveleak®, a protein-based tissue sealant, from Mallinckrodt plc. Preveleak® is used in vascular reconstruction and is made from bovine albumin serum and polyaldehyde. Ethicons fibrin sealant product, EVICEL®, is sourced from pooled human plasma. Integra was the leading competitor in the synthetic sealant market, with DuraSeal®. This product is indicated for intra-operative sealing of the dura, the outermost layer that protects the brain and spinal cord just under the bone.
About Our In-Depth MedCore Research
Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.
This MedCore is also found in the full report suite titled United States Market Report Suite for Wound and Tissue Management – MedSuite
